{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:26:19Z","timestamp":1793330779757,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000867","name":"Robert Wood Johnson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019688","name":"Department of Medicine, Georgetown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.eprac.2022.12.008","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:04:42Z","timestamp":1671275082000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review"],"prefix":"10.1016","volume":"29","author":[{"given":"Renata","family":"Arrington-Sanders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan T.","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Coon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Dowshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zil","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Grimstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle Marie","family":"Javier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia","family":"Poteat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Radix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colt","family":"St. Amand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carl G.","family":"Streed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Toribio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eprac.2022.12.008_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11920-018-0973-0","article-title":"Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition","volume":"20","author":"Nguyen","year":"2018","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"10.1016\/j.eprac.2022.12.008_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/appi.ajp.2019.19010080","article-title":"Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: a total population study","volume":"177","author":"Br\u00e4nstr\u00f6m","year":"2020","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eprac.2022.12.008_bib3","article-title":"Standards of care for the health of transsexual, transgender, and gender non-conforming people. 7th version","author":"Coleman","year":"2012","journal-title":"WPATH"},{"key":"10.1016\/j.eprac.2022.12.008_bib4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2018.03.005","article-title":"Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose","volume":"165","author":"Oedingen","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.eprac.2022.12.008_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A\u00a0systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.eprac.2022.12.008_bib6","article-title":"FDA drug safety communication: updated information about the risk of blood clots in women taking birth control pills\u00a0containing drospirenone","year":"2018","journal-title":"Food and Drug Administration"},{"issue":"13","key":"10.1016\/j.eprac.2022.12.008_bib7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"issue":"9382","key":"10.1016\/j.eprac.2022.12.008_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eprac.2022.12.008_bib9","first-page":"209","article-title":"Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy","volume":"10","author":"Goldstein","year":"2019","journal-title":"J\u00a0Blood Med"},{"issue":"3","key":"10.1016\/j.eprac.2022.12.008_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.008_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A\u00a0long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2022.12.008_bib12","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.008_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.008_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amepre.2021.05.019","article-title":"Cardiovascular disease in a population-based sample of transgender and cisgender adults","volume":"61","author":"Poteat","year":"2021","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.008_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Int Med"},{"issue":"11","key":"10.1016\/j.eprac.2022.12.008_bib16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.008_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.116.025024","article-title":"Smoking: a dual pathogen for arterial and venous thrombosis","volume":"135","author":"Anand","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2022.12.008_bib18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"New Engl J Med"},{"issue":"11","key":"10.1016\/j.eprac.2022.12.008_bib19","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jth.14626","article-title":"Transgender patients and the role of the coagulation clinician","volume":"17","author":"Connors","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.008_bib20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","article-title":"Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy","volume":"93","author":"Ott","year":"2010","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.eprac.2022.12.008_bib21","first-page":"1280","article-title":"Risk for venous thromboembolism in transgender patients undergoing cross-sex hormone treatment: a systematic review","volume":"18","author":"Kotamarti","year":"2021","journal-title":"J\u00a0Sex Med"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.008_bib22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.008_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in The\u00a0Netherlands","volume":"139","author":"van Ommen","year":"2001","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.008_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2011.03.052","article-title":"Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study","volume":"159","author":"Tuckuviene","year":"2011","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.008_bib25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/jth.15256","article-title":"Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen","volume":"19","author":"Scheres","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"10.1016\/j.eprac.2022.12.008_bib26","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1111\/jgs.14350","article-title":"Drug therapy for gender transitions and health screenings in transgender older adults","volume":"64","author":"Mahan","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"9","key":"10.1016\/j.eprac.2022.12.008_bib27","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/jgs.14279","article-title":"Pathogenesis, diagnosis, and treatment of venous thromboembolism in older adults","volume":"64","author":"Johnson","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.eprac.2022.12.008_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.thromres.2017.05.015","article-title":"Venous thromboembolism in the elderly: a narrative\u00a0review","volume":"155","author":"Tritschler","year":"2017","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.008_bib29","first-page":"79","article-title":"Frailty and risk of venous thromboembolism in older adults","volume":"62A","author":"Folsom","year":"2007","journal-title":"J\u00a0Gerontol"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.008_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0040-1701476","article-title":"Oral anticoagulation in the elderly and frail","volume":"40","author":"Bauersachs","year":"2020","journal-title":"H\u00e4mostaseologie"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.008_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejim.2014.03.009","article-title":"Diagnosis and management of pulmonary embolism in the elderly","volume":"25","author":"Robert-Ebadi","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.eprac.2022.12.008_bib32","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1538-7836.2005.01598.x","article-title":"Differential value of risk factors and clinical\u00a0signs for diagnosing pulmonary embolism according to age","volume":"3","author":"Le Gal","year":"2005","journal-title":"J\u00a0Thromb\u00a0Haemost"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.008_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/NCQ.0000000000000399","article-title":"Brown bag medication review: using AHRQ\u2019s brown bag medication tool","volume":"35","author":"Murtha","year":"2020","journal-title":"J\u00a0Nurs Care Qual"},{"issue":"6","key":"10.1016\/j.eprac.2022.12.008_bib34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1055\/s-0034-1389083","article-title":"Anticoagulation in the older adult: optimizing benefit and reducing risk","volume":"40","author":"Ko","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"19","key":"10.1016\/j.eprac.2022.12.008_bib35","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"13","key":"10.1016\/j.eprac.2022.12.008_bib36","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1503\/cmaj.160408","article-title":"Deep vein thrombosis in a transgender woman","volume":"189","author":"Chan","year":"2017","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.008_bib37","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/MPH.0000000000000984","article-title":"Hormone therapy and venous thromboembolism in a transgender adolescent","volume":"40","author":"Stanley","year":"2018","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"13","key":"10.1016\/j.eprac.2022.12.008_bib38","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended\u00a0treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.eprac.2022.12.008_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.eprac.2022.12.008_bib40","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.008_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.008_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18773\/austprescr.2019.003","article-title":"Prescribing for transgender patients","volume":"42","author":"Tomlins","year":"2019","journal-title":"Aust Prescr"},{"issue":"2","key":"10.1016\/j.eprac.2022.12.008_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1213\/ANE.0000000000003371","article-title":"The perioperative care of the transgender patient","volume":"127","author":"Tollinche","year":"2018","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.eprac.2022.12.008_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamasurg.2014.1841","article-title":"Surgical duration and risk of venous thromboembolism","volume":"150","author":"Kim","year":"2015","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.eprac.2022.12.008_bib45","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/AOG.0000000000002818","article-title":"ACOG committee opinion: perioperative pathways: enhanced recovery after surgery","volume":"132","author":"The American College of Obstetricians and Gynecologists Committee on Gynecologic Practice","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.eprac.2022.12.008_bib46","first-page":"395","article-title":"Hormone replacement therapy and risk for venous thromboembolism: what\u2019s new and how do these findings influence clinical practice?","volume":"12","author":"Douketis","year":"2005","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"10.1016\/j.eprac.2022.12.008_bib47","doi-asserted-by":"crossref","first-page":"e1586","DOI":"10.1210\/clinem\/dgaa966","article-title":"No venous thromboembolism increase among transgender female patients remaining on estrogen for gender-affirming surgery","volume":"106","author":"Kozato","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2 Suppl","key":"10.1016\/j.eprac.2022.12.008_bib48","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.eprac.2022.12.008_bib49","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.eprac.2022.12.008_bib50","first-page":"36","article-title":"Determination of risk factors for venous thromboembolism by an adapted Caprini scoring system in surgical patients","volume":"9","author":"Hanh","year":"2019","journal-title":"J\u00a0Pers Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.12.008_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/trgh.2015.0008","article-title":"A\u00a0systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals","volume":"1","author":"White Hughto","year":"2016","journal-title":"Transgender Health"},{"issue":"9","key":"10.1016\/j.eprac.2022.12.008_bib52","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jama.2011.1255","article-title":"Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education","volume":"306","author":"Obedin-Maliver","year":"2011","journal-title":"JAMA"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:14:23Z","timestamp":1761516863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22008989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1530891X22008989"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.12.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}